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Neuropathic pain and allodyniamay arise from sensi-
tization of central circuits. We report a mechanism of
disinhibition-based central sensitization resulting
from long-term depression (LTD) of GABAergic inter-
neurons as a consequence of TRPV1 activation in
the spinal cord. Intrathecal administration of TRPV1
agonists led to mechanical allodynia that was not
dependent on peripheral TRPV1 neurons. TRPV1
was functionally expressed in GABAergic spinal
interneurons and activation of spinal TRPV1 resulted
in LTD of excitatory inputs and a reduction of inhibi-
tory signaling to spinothalamic tract (STT) projection
neurons. Mechanical hypersensitivity after periph-
eral nerve injury was attenuated in TRPV1/ mice
but not in mice lacking TRPV1-expressing peripheral
neurons. Mechanical pain was reversed by a spinally
applied TRPV1 antagonist while avoiding the hyper-
thermic side effect of systemic treatment. Our results
demonstrate that spinal TRPV1 plays a critical role as
a synaptic regulator and suggest the utility of central
nervous system-specific TRPV1 antagonists for
treating neuropathic pain.
INTRODUCTION
Pain hypersensitivity generated by peripheral injury can result
from plastic changes in both the peripheral (Campbell and
Meyer, 2006; Finnerup et al., 2007) and central nervous systems
(CNSs) (Costigan et al., 2009; Coull et al., 2003; Ikeda et al.,
2003). Mechanical allodynia, pain response to light touch, is
the most common and challenging symptom found in patholog-
ical pain (Campbell and Meyer, 2006). The mechanisms under-
lying induction and maintenance of mechanical hypersensitivity640 Neuron 74, 640–647, May 24, 2012 ª2012 Elsevier Inc.are still uncertain (Costigan et al., 2009), but the dominant pop-
ulation of Nav1.8-expressing peripheral neurons that mediate
acute mechanical and thermal pain are not required (Abraham-
sen et al., 2008). The transmission of pain signals from primary
afferent neurons to higher brain centers is controlled by a balance
between excitatory and inhibitory signaling in the spinal cord
dorsal horn (Kuner, 2010). A key area for pain processing is the
substantia gelatinosa (SG) of the spinal dorsal horn and inhibitory
SG interneurons have been proposed as a gate of pain transmis-
sion and other sensory modalities to higher brain centers
(Melzack andWall, 1965). It has been suggested that a reduction
in tonic and phasic inhibitory control or ‘‘disinhibition’’ in the
spinal dorsal horn is responsible for the amplification of pain
messages that produces hyperalgesia and allodynia (Sivilotti
and Woolf, 1994; Yaksh, 1989) following peripheral nerve injury
(Basbaum et al., 2009; Moore et al., 2002). Thus, central rather
than peripheral mechanisms appear to be responsible for the
hyperexcitability of nociceptive signaling leading to neuropathic
mechanical allodynia (Costigan et al., 2009; Coull et al., 2003;
Torsney and MacDermott, 2006; Woolf et al., 1992).
TRPV1 antagonists have shown efficacy in animal models of
both inflammatory and neuropathic pain (Patapoutian et al.,
2009) but systemic administration of TRPV1 antagonists
commonly results in hyperthermia caused by peripheral
TRPV1 blockade (Steiner et al., 2007). Activation of spinal
TRPV1 can generate central sensitization and mechanical allo-
dynia (Patwardhan et al., 2009) and spinal administration of
TRPV1 antagonists can attenuate mechanical allodynia induced
by nerve injury (Patapoutian et al., 2009), but the cell types or
circuits underlying these effects are unknown. Mechanical allo-
dynia associated with TRPV1 activation is unlikely to depend on
TRPV1-expressing primary sensory neurons as these are not
necessary for the transduction of painful mechanical stimuli
(Cavanaugh et al., 2009) and a mechanical pain phenotype is
not observed in TRPV1/ mice (Caterina et al., 2000). Thus,
the mechanism of action for TRPV1 antagonism in neuropathic
mechanical pain relief remains unknown. The expression of
TRPV1 in spinal cord SG neurons has recently been suggested
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Figure 1. Spinal TRPV1 in Central Neurons Mediates Mechanical Allodynia
(A and B) Mechanical thresholds were measured after intrathecal administration of capsaicin. (A) Time course after injection of capsaicin (1 mg, n = 6), capsaicin
(1 mg) with BCTC (10 mg, n = 6), and vehicle with BCTC alone (10 mg, n = 5) in naive mice. (B) Time course after injection of capsaicin (1 mg) in TRPV1/ (n = 5) and
RTX-treated mice (n = 6). One-way repeated-measures ANOVA of changes in mechanical threshold by capsaicin, *p < 0.05, **p < 0.005.
(C) Expression level of TRPV1 mRNA was markedly decreased in dorsal root ganglion but not in spinal cord (n = 3, unpaired t test; **p < 0.001) 7 days after
intraperitoneal injection of RTX.
(D–G) Electron microscopic immunostaining for TRPV1 in the superficial lamina of the spinal dorsal horn in naive (D–F) and TRPV1/ mice (G). (D) TRPV1
immunostaining is observed in an axon terminal containing spherical vesicles that is presynaptic to a dendrite, (E) in a dendrite that is postsynaptic to an axon
terminal and (F) within somata (inset; higher magnification of boxed area). (G) TRPV1 immunostaining is completely abolished in the spinal dorsal horn of the
TRPV1/ mice. Arrow indicates TRPV1 immunoreaction product.
At, axon terminal; d, dendrite. Scale bar, 200 nm in (D)–(F) inset, and (G) and 1 mm in (F). All error bars represent SEM.
See also Figure S1 and Table S1.
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Spinal TRPV1 Mediates Mechanical Allodynia(Ferrini et al., 2010). Therefore, we speculated that central
TRPV1 may be involved in neuropathic mechanical pain. Here,
we explored the role of spinal TRPV1 in the spinal cord nocicep-
tive circuitry and further investigated its contribution to the
enhancement of mechanical pain sensitivity after peripheral
nerve injury.
RESULTS
Spinal TRPV1 Activation in SG Neurons Produces
Mechanical Allodynia
We first examined the relative contribution of peripheral and
central TRPV1 to the development of mechanical allodynia
inducedby theTRPV1agonist capsaicin.Consistentwitha recent
report (Patwardhan et al., 2009), intrathecal administration of
capsaicin in mice decreased the paw withdrawal mechanical
threshold (Figure 1A). This effectwasprevented by coadministra-
tion of the TRPV1-selective antagonist N-(4-tertiarybutylphenyl)-
4-(3-chloropyridin-2-yl) tetrahydropyrazine-1(2H)-carbox-amide
(BCTC, Figure 1A). Capsaicin had no effect on mechanical
thresholds in TRPV1/ mice (Figure 1B). Intrathecal capsaicincould act on either postsynaptic TRPV1 expressed in spinal
cord neurons or on presynaptic TRPV1 expressed at the primary
afferent terminals of sensory neurons. To distinguish between
these possibilities, we generated mice in which TRPV1-express-
ing peripheral neurons are ablated by intraperitoneal injection of
the ultrapotent TRPV1 agonist resiniferatoxin (RTX). RTX treat-
ment eliminated TRPV1 mRNA in dorsal root ganglia without
alteringmRNA levels in the spinal cord (Figure 1C). RTX treatment
appeared to be effective in completely ablating peripheral
neurons expressing TRPV1, including their central terminals,
because there was complete loss of TRPV1 immunoreactivity in
DRG neurons (Figures S1A and S1B available online), nearly
complete (98%) loss of capsaicin-induced calcium increases in
DRG cell bodies (Figure S1D), and complete loss of capsaicin
response of presynaptic terminals (Figure S1C). However, in
contrast to TRPV1/ mice, intrathecal capsaicin injection was
still able to effectively induce mechanical hypersensitivity in
RTX-treated mice (Figure 1B), suggesting a site of action on
central neurons. High-resolution electron microscopic analysis
of the lumbar spinal cord revealed TRPV1 was localized not
only to presynaptic terminals, as expected (Figure 1D), but alsoNeuron 74, 640–647, May 24, 2012 ª2012 Elsevier Inc. 641
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Figure 2. TRPV1 Is Functionally Expressed by GAD-Positive SG Neurons
(A) Electron micrograph of immunoperoxidase staining for TRPV1 combined with immunogold labeling for glutamic acid decarboxylase (GAD) in spinal dorsal
horn of mice. TRPV1 (arrow) and GAD (arrow head) were detected in the same dendrites. Scale bar, 500 nm.
(B) Single-cell RT-PCR revealed that TRPV1 mRNA was expressed predominantly in a population of GAD65-EGFP positive SG neurons (n = 23/30) but in also in
a small population of GAD65-EGFP negative SG neurons (n = 5/20, ***p = 0.0005, Fisher’s exact test).
(C and D) Functional expression of TRPV1 in GAD65-EGFP positive SG neurons. (C) Capsaicin (CAP, 2 mM)-induced currents were blocked by 50 mM 6-iodo-
nordihydrocapsaicin (6-iodo-CAP, n = 6, *p = 3.61e-8). (D) I–V relationship (90 to +40 mV) obtained from capsaicin-induced currents.
All error bars represent SEM.
See also Figure S2 and Table S2.
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Spinal TRPV1 Mediates Mechanical Allodyniato postsynaptic dendrites in the dorsal horn (Figure 1E), andpost-
synaptic cell soma (Figure 1F). No TRPV1 immunoreactivity was
observed in the dorsal horn of TRPV1/ mice (Figure 1G).
TRPV1 Is Functionally Expressed by GABAergic SG
Neurons
We next sought to identify the population of postsynaptic spinal
cord neurons that functionally express TRPV1. SG neurons of the
spinal dorsal horn are a heterogenous population of interneurons
(Maxwell et al., 2007; Todd and McKenzie, 1989) that receive
direct inputs from primary afferent fibers (Yasaka et al., 2007).
TRPV1 immunoreactivity was colocalized in postsynaptic
dendrites with the GABA synthesizing enzyme glutamic acid de-
carboxylase 65 (GAD65) (Figure 2A). TRPV1 mRNA was de-
tected in 76.7% of GAD65-enhanced green fluorescent protein
(EGFP) positive SG neurons by single-cell RT-PCR (Figure 2B,
upper). In contrast, the occurrence of TRPV1 mRNA in GAD65-
EGFP negative SG neurons was lower (25%, Figure 2B, lower).
To test for functional expression of TRPV1, we applied capsaicin
(CAP) to spinal cord slices while recording from SG neurons. In
addition to eliciting spontaneous excitatory postsynaptic
currents (EPSCs), as expected from activation of presynaptic
TRPV1 (Figure S2A), capsaicin also elicited clear whole-cell
currents in SG neurons (Figure S2B) that persisted in the pres-
ence of a cocktail of neurotransmission blockers including642 Neuron 74, 640–647, May 24, 2012 ª2012 Elsevier Inc.6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), amino-5-phos-
phonovaleric acid (AP5), picrotoxin, strychnine, and tetrodotoxin
with highMgCl2 and a calcium chelator (see Experimental Proce-
dures). Whole-cell capsaicin-induced currents (16.5 ± 2.5 pA)
were recorded in identified GAD65-positive SG neurons; these
currents were blocked by the TRPV1 antagonist 6-iodo-nordihy-
drocapsaicin (6-iodo-capsaicin, 18.70% ± 1.47%, Figure 2C)
and showed outward rectification with a reversal potential of
0 mV characteristic of TRPV1-mediated currents (Caterina
et al., 1997; Figure 2D and Figure S2C). A high proportion of
these functionally TRPV1-positive, GAD65-positive SG neurons
displayed a long-lasting tonic- or phasic-firing pattern (Fig-
ure S2D) characteristic of inhibitory spinal cord interneurons
(Cui et al., 2011). These results show that TRPV1 is functionally
expressed in a substantial subpopulation of GABAergic SG
neurons.
Postsynaptic Spinal TRPV1 Mediates LTD via AMPA
Internalization in GABAergic SG Neurons and Results in
Depression of Inhibitory Input to Projection Neurons
We next examined the role of postsynaptic spinal TRPV1 in the
spinal cord synaptic circuitry involving GAD65-positive SG
neurons. Application of capsaicin induced a long-lasting depres-
sion of EPSCs evoked in SG neurons by electrical stimulation of
the dorsal root entry zone (DREZ). This effect of capsaicin was
Neuron
Spinal TRPV1 Mediates Mechanical Allodyniaabolished in slices prepared from TRPV1/mice and also when
intracellular 6-iodo-capsaicin was introduced by the patch
pipette (Figure 3A). Consistent with a postsynaptic action of
capsaicin in LTD, the inclusion of 6-iodo-capsaicin in the patch
pipette did not inhibit spontaneous EPSCs induced by presyn-
aptic-TRPV1 activation (Figure S3A). The capsaicin-induced
LTD persisted in RTX-treated mice (Figure 3B) and capsaicin
did not affect the paired-pulse ratio (Figure 3C), suggesting
that the LTD is independent of TRPV1-expressing afferents
and is not mediated by changes in presynaptic neurotransmitter
release. Capsaicin-induced LTD was not observed when intra-
cellular calcium was buffered by 1,2-bis(o-aminophenoxy)
ethane-N,N,N0,N0-tetraacetic acid (BAPTA) in the recording
pipette (Figure 3B) confirming that elevation of postsynaptic of
calcium is required for synaptic depression by capsaicin. The
capsaicin-induced LTD of EPSC was not dependent on the
activity of NMDA receptors, group I and II metabotropic gluta-
mate receptors (mGluR), or the substance P receptor neurokinin
1 as the effect was not blocked by application of the antagonists
AP5 (50 mM), Hexyl-HIBO (HIBO, Group I mGluR antagonist,
200 mM), LY341495 (Group II mGluR antagonist, 100 mM) (Fig-
ure 3B), (RS)-a-methyl-4-carboxyphenylglycine (MCPG, nonse-
lective group I/group II mGluR antagonist, 500 mM) and
L-703,606 (10 mM) (Figure S3B), respectively. Thus, we tested
the involvement of alpha-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA) receptors as a likely candidate medi-
ating TRPV1-dependent synaptic inhibition. We observed that
whole-cell currents elicited by focal application of AMPA were
reduced after capsaicin application (68.08% ± 3.39%, Fig-
ure 3D); the reduction in AMPA current was not observed in
the presence of 6-iodo-capsaicin (Figures S3C and S3D). This
finding was consistent with a postsynaptic locus and suggested
altered membrane expression of AMPA receptors. Indeed,
following capsaicin application to spinal cord slices we observed
a reduction in membrane expression of AMPA receptor subunit
GluR2 protein (60.4% ± 9.8%), the main AMPA subunit in the
SG (Polga´r et al., 2008; Figure 3E).
To examine the functional consequences of capsaicin-induced
LTD in GABAergic SG interneurons, we retrogradely labeled spi-
nothalamic tract (STT) projection neurons by injection of 1,10,di-
octadecyl-3,3,3030-tetramethylindocarbocyanine perchlorate (DiI)
into the ventroposterolateral (VPL) subnucleus of the thalamus
(Figure 3F). Labeled neurons were located in the deep lamina of
thespinaldorsal hornandshowed inhibitorypostsynapticcurrents
(IPSCs) in response to DREZ stimulation (Figure 3F and Figure S4)
that were blocked by CNQX (10 mM) and AP5 (50 mM), confirming
their polysynaptic nature. The amplitude of DREZ-evoked IPSCs
in STT neurons from wild-type (Wt) and RTX-treated mice was
decreased after capsaicin application, and depression of IPSCs
(Wt, 56%± 11%; RTX-treatedmice, 65%± 9%) lasted for at least
15 min (Figure 3F). The reduction in IPSC amplitude was not the
result of a direct action of capsaicin on STT neurons as TRPV1
mRNA was not detected in STT neurons by single-cell RT-PCR
(Figure 3F). Together, these data suggest that activation of
TRPV1 leads to depression of excitatory input to GABAergic
SG interneurons by a postsynaptic mechanism involving intracel-
lular calcium-dependent GluR2 internalization, thus resulting in
reduced inhibitory input to STT neurons (Figure 3G).Postsynaptic Spinal TRPV1 Is Involved in the
Maintenance of Chronic Mechanical Allodynia after
Nerve Injury
To determine whether activation of spinal TRPV1 plays a role in
the development of neuropathic pain, we measured mechanical
sensitivity in a chronic constriction injury (CCI) model. Accumu-
lating mechanical hypersensitivity up to 28 days after CCI was
attenuated by 41% in TRPV1/ mice (Figures 4A and 4C)
but not in RTX-treated mice (Figure 4B and 4C). Furthermore,
spinal TRPV1 inhibition by intrathecal administration of BCTC
dose-dependently alleviated chronic mechanical pain in RTX-
treated mice following CCI (Figures 4D and 4E). By restricting
TRPV1 blockade to the spinal cord central nervous system
(CNS) using intrathecal injection, we were able to avoid the
induction of hyperthermia that occurred with systemic (intrave-
nous) administration of BCTC (Figure 4F).
DISCUSSION
We have shown that activation of postsynaptic spinal TRPV1
leads to decreased functional AMPA receptor expression in
GABAergic SG interneurons and thus reduced excitation of
a key population of inhibitory interneurons. Our observation of
reduced inhibitory synaptic signaling to STT neurons of the
deep lamina suggests a mechanism of disinhibition of spinal
cord projection neurons that are critical for the relay of nocicep-
tive signals to higher brain centers. Using the sciatic nerve CCI
model in TRPV1/ mice we uncover a substantial role of
TRPV1 in neuropathic mechanical pain. We observed 41%
reversal of CCI-induced mechanical allodynia by spinal applica-
tion of the TRPV1 antagonist BCTC in RTX-treated mice (Fig-
ure 4D and 4E) revealing that endogenous activation of spinal
TRPV1, possibly by GPCRs (Kim et al., 2009) or arachidonic
acid (AA) metabolites (Gibson et al., 2008) such as 12-hydroper-
oxyeicosatetraenoic acid (12-HPETE) (Figure S5) contributes to
the maintenance of chronic mechanical allodynia after neuro-
pathic nerve injury. Our observations also correlate with findings
showing that TRPV1 antagonists with greater CNS penetration
are more potent for reducing mechanical allodynia (Cui et al.,
2006; Patapoutian et al., 2009). Finally, we have shown that by
targeting spinally mediated chronic pain we can avoid the side
effects of peripheral TRPV1 blockade on temperature homeo-
stasis (Steiner et al., 2007).
Our results help to clarify prior controversy surrounding the
role of TRPV1 by explaining how it is that TRPV1 antagonists
can reduce neuropathic mechanical pain (Cui et al., 2006; Pata-
poutian et al., 2009) even though TRPV1-expressing primary
sensory neurons do not convey physiological mechanical pain
(Cavanaugh et al., 2009). By using RTX to ablate TRPV1-ex-
pressing primary afferents, we were able to functionally isolate
the contribution of postsynaptic TRPV1; however, further study
into spinal TRPV1-mediated plasticity may require conditional
TRPV1 knockout in DRG neurons. A recent study using
a TRPV1 reporter mouse showed that there are very few cells
in the CNS that express TRPV1 (Cavanaugh et al., 2011); our
results using both immuno EM and electrophysiology show
that a subpopulation of interneurons in the SG are among these.
The TRPV1-mediated currents in these SG neurons were smallNeuron 74, 640–647, May 24, 2012 ª2012 Elsevier Inc. 643
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Figure 3. Capsaicin-Induced LTD via Reduction of Membrane GluR2 in GAD-Positive SGNeurons Results in Depression of Inhibitory Input to
STT Neurons in Spinal Cord
(A) CAP (2 mM for 5 min) induced LTD of eEPSCs (Vh =70 mV, n = 9) in GAD65-EGFP positive SG neurons that was blocked by intra-pipette 6-iodo-CAP (50 mM,
n = 5) and was absent in TRPV1/ mice (n = 5).
(B) CAP-induced LTD was blocked by internal administration of calcium chelator, 1,2-bis(o-aminophenoxy)ethane-N,N,N0,N0-tetraacetic acid (BAPTA, 10 mM,
n = 6), but not by amino-5-phosphonovaleric acid (AP5, NMDA-R blocker, 50 mM, n = 8) or Hexyl-HIBO (HIBO, Group I mGluR antagonist, 200 mM) with LY341495
(Group II mGluR antagonist, 100 mM) (n = 7). Administration of CAP consistently induced LTD in RTX-treated mice (n = 6).
(C) Paired pulse ratio was obtained by a pair of stimuli given at 50 ms intervals (n = 7).
(D) AMPA-induced currents were elicited by 100 mM AMPA puffing (20–200 ms, 3 min interval repeated puffing) at 70 mV holding potential. Bath application of
capsaicin (2 mM, 5 min) decreased AMPA-induced currents (n = 6, *p = 2.27e-4).
(E) GluR2 receptors in membrane fraction was reduced by CAP (5 mM for 10 min and washout for 30 min) in lumbar spinal cord of wild-type mice, but not in
TRPV1/ mice (n = 3, for each group, *p = 0.016).
(F) Single-cell RT-PCR revealed no mRNA expression of TRPV1 in spinothalamic tract (STT) neurons. In STT neurons from both wild-type (Wt) and RTX-treated
mice, evoked IPSCs at 0 mV following stimulation of dorsal root entry zone (DREZ) were reduced by CAP (2 mM for 5 min and washout for 10 min, Wt;
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Figure 4. Chronic Mechanical Allodynia by Nerve Injury Is Alleviated by Blockade of Postsynaptic TRPV1 in Spinal Cord
(A and B) Changes in the mechanical thresholds after sciatic nerve chronic constriction injury (CCI) were measured in TRPV1+/+, TRPV1/, vehicle-treated and
RTX-treated mice (n = 6 for each group). One-way repeated-measures ANOVA followed by Bonferroni’s test; **p < 0.001 (naive mice), #p < 0.05, ##p < 0.001
(TRPV1/ mice versus Presurgical value (1 day), t test; J p < 0.05 (TRPV1+/+ versus TRPV1/ or vehicle-treated versus RTX-treated).
(C) Mechanical hypersensitivity was calculated as the percentage difference in the mechanical thresholds of ipsilateral and contralateral hind paws accumulated
from each time point up to 28 days after CCI (n = 6 for each group). One-way ANOVA followed by Bonferroni’s test; *p = 0.0051 (Wt versus TRPV1/).
(D) Intrathecal injection of BCTC in RTX-treated mice reversed chronic mechanical hypersensitivity at 28 days after CCI in a dose-dependent manner (n = 6 for
each group).
(E) The data were normalized and displayed as the maximum possible effect (MPE). Two-way ANOVA, Bonferroni’s test; *p < 0.05, **p < 0.01.
(F) Rectal body temperature measured after intravenous (i.v.) injection of BCTC (3 mg/kg) or vehicle only (50% DMSO in saline) compared with high dose
intrathecal (i.t.) injection of BCTC (100 mg). (n = 4 mice per group).
Two-way ANOVA, Bonferroni’s test; *p < 0.05, **p < 0.01. All error bars represent SEM.
See also Figure S5.
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Spinal TRPV1 Mediates Mechanical Allodynia(17 pA on average), corresponding to activation of only a few
dozen TRPV1 channels. Nevertheless, we find that this sparse
expression of postsynaptic TRPV1 channels in a key population
of neurons has major functional consequences, playing a critical
role in mediating mechanical allodynia.
Together with TRPV1-mediated synaptic plasticity recently
demonstrated in hippocampus (Gibson et al., 2008), dentate
gyrus (Cha´vez et al., 2010), and nucleus accumbens (Grueter
et al., 2010), this work provides further evidence for the func-
tional significance and physiological implications of TRPV1 in
the CNS. In particular, our results show that TRPV1 expression
in a key population of spinal cord neurons underlies a critical
role as modulator of pain transmission in spinal circuits distinctn = 6, RTX; n = 7, One-way ANOVA, Bonferroni’s test; *p < 0.05 (Control vers
nonsignificant.
(G) Schematic representation of TRPV1 activation in GABAergic SG neurons a
through disinhibition of nociceptive circuitry in the spinal cord.
All error bars represent SEM.
See also Figures S3 and S4 and Table S2.from its well-known role as a molecular transducer of pain in
primary sensory neurons.
EXPERIMENTAL PROCEDURES
Detailed protocols are listed in Supplemental Experimental Procedures.
Animals
All surgical and experimental procedures were reviewed and approved by the
Institutional Animal Care and Use Committee at the School of Dentistry, Seoul
National University. Animal treatments were performed according to the
guidelines of the International Association for the Study of Pain. Adult
C57BL/6J (wild-type) male mice, heterozygous GAD65-EGFP mice, and
TRPV1/ mice of C57BL/6J background were used.us Wt-CAP or RTX-CAP group), n.s. (Wt-CAP versus RTX-CAP group). n.a.,
nd hypothesized sequence of events for the genesis of pain hypersensitivity
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To assess mechanical sensitivities, the withdrawal threshold of the hindpaw
was measured using a series of von Frey filaments (Stoelting, Wood Dale,
IL). All behavioral testing was performed by an investigator who was blind to
the treatment group and genetic background of the mice.
Intrathecal Injection
Drugs or vehicle (5 ml) was injected at the level of the lumbar enlargement using
a 25 ml Hamilton syringe fitted with a 31 gauge needle.
RTX Ablation of Peripheral TRPV1-Expressing Neurons
Three- to four-week-old mice were intraperitoneally injected with RTX dis-
solved in a mixture of 10% Tween-80 and 10% ethanol in normal saline or
vehicle alone under isoflurane anesthesia as a single bolus in two injections
of 50 mg/kg and 150 mg/kg on days 1 and 2, consecutively. RTX-treated
mice were used in experiments at least 7 days after final RTX injection.
Real-Time RT-PCR
Real-time PCR was performed using a 7500 Real-Time PCR system (Applied
Biosystems). All DCt values were normalized to GAPDH. The PCR primer
sequences used in this study are listed in Table S1A.
Visualized Whole-Cell Patch Clamp Recordings
Transverse slices (300 mm) were prepared from C57BL/6J or GAD65-EGFP
mice (4–6 weeks old). Whole-cell patch clamp recordings of spinal cord SG
and STT neurons were performed at room temperature (25C ± 1C). To
prevent spontaneous synaptic activity, a cocktail of neurotransmission inhibi-
tors were added (in mM): 10 CNQX; 50 D-AP5, 10 picrotoxin, 2 strychnine, 0.5
tetrodotoxin. For the composition of all internal and modified aCSF solutions
see Supplemental Experimental Procedures.
Synaptically Evoked Current Recordings
To record EPSCs, SG neurons were held at70mV. Electrical stimuli (0.01ms,
0.066 Hz) were delivered through a bipolar, Teflon-coated tungsten electrode,
whichwas placed in DREZ of spinal cord andmonosynaptic EPSCswere iden-
tified on the basis of the absence of conduction failure of evoked EPSCs. To
record evoked inhibitory postsynaptic currents (eIPSCs) from STT neurons,
the DiI-labeled neurons were held at 0 mV.
Single-Cell RT-PCR
Under fluorescence microscopy, GAD65-EGFP SG neurons and DiI-labeled
STT neurons were verified in spinal cord slices. Identified cells were collected
into a patch pipette with a tip diameter of about 20 mm and gently put into
a reaction tube containing reverse transcription reagents. All PCR amplifica-
tions were performed with nested primers (Table S1B).
Western Blotting Analysis
Spinal cord slices (700 mm) were incubated in 95% O2/5% CO2 saturated
recording aCSF with 5 mM capsaicin for 10 min at 32C followed by washed
out for 30 min. Spinal cord slices were homogenized and centrifuged and
protein concentration was determined with BCA assay kit (Pierce). Equal
amounts of proteins were separated by SDS-PAGE electrophoresis and trans-
ferred onto PVDF membrane. After blocking, the membrane was probed with
primary antibodies overnight followed by horseradish peroxidase-conjugated
secondary antibodies for 1 hr at room temperature. Blots were developed by
chemiluminescence reagent (West-zol, Intron) exposure to photographic film
and quantified. Independent experiments were conducted at least three
times.
Application of Retrograde Tracer into VPL Region of Thalamus
Under pentobarbital sodium (40 mg/kg) anesthesia, DiI (Molecular Probes;
1 ml, 25 mg/0.5 ml in ethanol) was injected into the VPL region of the thalamus
(Bregma: 1.2 ± 0.2 mm, midline: 1.9 ± 0.2 mm, depth: 3.2 ± 0.2 mm) using
a glass micropipette (20 mm tip diameter) which was guided to the target
area using a stereotaxic apparatus (Narishige, Tokyo, Japan).646 Neuron 74, 640–647, May 24, 2012 ª2012 Elsevier Inc.Chronic Constriction Injury Model
Two silk sutures (7-0; Ailee, Busan, Korea) were tied loosely around the full
circumference of the sciatic nerve 2–3 mm apart and secured with a reef
knot; intraneural blood flow was not impeded. For reversal of chronic mechan-
ical allodynia, BCTC was intrathecally injected at 28 days after CCI surgery.
Rectal Temperature Recording
Rectal temperature was measured by insertion of a flexible bead probe with
a digital thermometer (TC-324B, Warner Instrument Corp., Hamden, CT).
Drugs
All drugs were made as stock solutions and keep at20C and diluted as final
concentration (1:1,000–5,000).
Statistical Analyses
We expressed data asmean ± SEM, unless otherwise indicated. Significances
in 50% pawwithdrawal thresholds in comparison with preinjection or preinjury
levels were calculated by one-way repeated-measure ANOVA followed by
Bonferroni’s post-test and Student’s unpaired t test.
Detailed methodology can be found in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.neuron.2012.02.039.
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